Skip to main content
Clinical Trials/NCT05674084
NCT05674084
Recruiting
Not Applicable

Influence of Vasopressor Support and Mean Arterial Pressure on Capillary Refill Time Values in Critically Ill Patients: Prospective, Observational Study

Medical University of Silesia1 site in 1 country150 target enrollmentDecember 3, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Critical Illness
Sponsor
Medical University of Silesia
Enrollment
150
Locations
1
Primary Endpoint
Effect of norepinephrine dose on CRT value
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The goal of this observational study is to learn whether different doses of various vasopressor drugs influence capillary refill time (CRT) value in crtically ill patients. The main questions it aims to answer are:

  • How do vasopressor drugs determine CRT value
  • How does mean arterial pressure (MAP) determine CRT value
  • How often CRT value is normal (< 3 sec) despite hypotensive MAP (<65 mmHg)

Participants will have the CRT measured over the course of the ICU hospitalization. At the end of the study, multiple linear regression will be performed to verify whether different doses of vasopressor drugs influence CRT value.

Detailed Description

The goal of this observational study is to learn whether different doses of various vasopressor drugs influence capillary refill time (CRT) value in critically ill patients. The main questions it aims to answer are: * How does norepinephrine dose influence CRT value * How does epinephrine dose influence CRT value * How does argipressin dose influence CRT value * How does dobutamine dose influence CRT value * How does mean arterial pressure (MAP) determine CRT value * How often CRT value is normal (\< 3 sec) despite hypotensive MAP (\<65 mmHg) Participants will have the CRT measured over the course of the ICU hospitalization. At the end of the study, multiple linear regression will be performed to verify whether different doses of vasopressor drugs influence CRT value. CRT will be a dependent variable. Independent variables will be as follows: age, MAP, norepinephrine dose, epinephrine dose, argipressin dose, dobutamine dose. CRT measurements will be performed in a standarized rigor (light, chronometer, pressure and ambient temperature will be the same in all patients)

Registry
clinicaltrials.gov
Start Date
December 3, 2022
End Date
December 31, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Łukasz Krzych

Professor

Medical University of Silesia

Eligibility Criteria

Inclusion Criteria

  • critical illness requiring vasopressor support
  • invasive blood pressure monitoring

Exclusion Criteria

  • finger distal phalanx not available
  • patient in a room of suboptimal ambient temperature

Outcomes

Primary Outcomes

Effect of norepinephrine dose on CRT value

Time Frame: Through study completion, an average of 1 year

In a multiple linear regression, it will be verified whether different doses of norepinephrine determine CRT value.

Effect of mean arterial pressure on CRT value

Time Frame: Through study completion, an average of 1 year

In a multiple linear regression, it will be verified whether different values of MAP determine CRT value.

Secondary Outcomes

  • Effect of dobutamine dose on CRT value(Through study completion, an average of 1 year)
  • Effect of argipressin dose on CRT value(Through study completion, an average of 1 year)
  • CRT value in MAP <65 mmHg(Through study completion, an average of 1 year)
  • Effect of epinephrine dose on CRT value(Through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials